Skip to content

    Recently Viewed

      Listening...

      Home / Latest news /
      Global Trial Finder: Why it just got easier to enroll in a Janssen clinical study
      Global Trial Finder

      Global Trial Finder: Why it just got easier to enroll in a Janssen clinical study

      Share Article
      share to

      More than 35,000 of the world’s most dedicated scientists and innovators work for the Janssen Pharmaceutical Companies of Johnson & Johnson, helping to research and develop new ways to treat and prevent some of the world’s most complex diseases.

      But there’s another key component that’s necessary when it comes to finding new therapies for conditions like Alzheimer’s disease, rheumatoid arthritis and cancer: you.

      Janssen Research & Development routinely conducts clinical trials to evaluate investigational medications and treatment regimens, and that requires the participation of hundreds—sometimes even thousands—of volunteers.

      But finding enough willing and qualified participants can often be a challenge.

      Enter the Janssen Global Trial Finder, an easy-to-use database of clinical trials that are currently accepting new participants for a variety of diseases. People interested in enrolling in a study can search by medical condition and geographic location.

      “We understand both the health-related reasons people seek to participate in clinical trials, and the motivation to help others who may face similar experiences in the future,” says Bert Hartog, Ph.D., Director and Clinical Trial Innovation Lead at Janssen. “So we wanted to offer a resource for easily accessing our clinical trials globally—a resource that can enable us to continue to advance innovative medicines to treat, prevent, intercept and cure some of the most complex diseases of our time.”

      More from Johnson & Johnson

      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      Innovation
      Headshots of three Johnson and Johnson female scientists

      Meet 3 leaders who are breaking new ground for women in healthcare

      For International Women’s Day, celebrate the achievements of these amazing female scientists and researchers at Johnson & Johnson.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.